As of 2026-01-07, the Relative Valuation of Blueprint Medicines Corp (BPMC) is (36.12) USD. This relative valuation is based on P/E multiples. With the latest stock price at 129.46 USD, the upside of Blueprint Medicines Corp based on Relative Valuation is -127.9%.
The range of the Relative Valuation is (33.91) - (38.72) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.1x - 16.5x | 14.4x |
| Forward P/E multiples | 13.7x - 16.1x | 15.6x |
| Fair Price | (33.91) - (38.72) | (36.12) |
| Upside | -126.2% - -129.9% | -127.9% |
| Date | P/E |